Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
J Surg Res. 2022 Sep;277:1-6. doi: 10.1016/j.jss.2022.03.016. Epub 2022 Apr 19.
While adrenal venous sampling (AVS) differentiates between the unilateral and bilateral disease in patients with primary aldosteronism (PA), it is unknown if AVS can determine laterality of pheochromocytoma in patients with bilateral adrenal masses. This study analyzes adrenal vein (AV) epinephrine and norepinephrine levels in nonpheochromocytoma patients to determine the "normal" range.
We reviewed patients who underwent AVS for PA between 2009 and 2019 at a single institution; pheochromocytoma was excluded. Aldosterone, cortisol, epinephrine, and norepinephrine levels were obtained from the inferior vena cava (IVC), left adrenal vein (LAV), and right adrenal vein (RAV). Successful AV cannulation was defined by an AV/IVC cortisol ratio of ≥3:1 or an AV epinephrine level ≥364 pg/mL. Plasma measurements (pg/mL) are median values with interquartile ranges; normal ranges for epinephrine and norepinephrine are 10-200 pg/mL and 80-520 pg/mL, respectively.
AVS was performed in 172 patients in 405 AVs (173 LAV and 232 RAV). Median epinephrine levels were IVC = 19 (14 and 34), LAV = 3811 (1870 and 6915), and RAV = 2897 (1500 and 5288). Median norepinephrine levels were IVC = 325 (186 and 479), LAV = 1450 (896 and 2050), and RAV = 786 (436 and 1582). There was a difference between LAV and RAV epinephrine levels (P = 0.024) and between LAV and RAV norepinephrine (P = 0.002) levels.
This extensive experience with AVS demonstrated a wide range of "normal" AV catecholamine levels in patients without pheochromocytoma, which suggests that the utility of AVS to determine disease laterality in patients with pheochromocytoma and bilateral adrenal nodules is likely to be limited.
虽然肾上腺静脉采样(AVS)可区分原发性醛固酮增多症(PA)患者的单侧和双侧疾病,但尚不清楚 AVS 是否可确定双侧肾上腺肿块患者嗜铬细胞瘤的侧别。本研究分析了非嗜铬细胞瘤患者的肾上腺静脉(AV)去甲肾上腺素和肾上腺素水平,以确定“正常”范围。
我们回顾了 2009 年至 2019 年期间在一家单机构进行 AVS 以治疗 PA 的患者;排除了嗜铬细胞瘤。从下腔静脉(IVC)、左肾上腺静脉(LAV)和右肾上腺静脉(RAV)获取醛固酮、皮质醇、肾上腺素和去甲肾上腺素水平。AVS 成功定义为 AV/IVC 皮质醇比值≥3:1 或 AV 肾上腺素水平≥364pg/mL。血浆测量值(pg/mL)为中位数及其四分位距;肾上腺素和去甲肾上腺素的正常值分别为 10-200pg/mL 和 80-520pg/mL。
在 172 例患者的 405 次 AVs(173 次 LAV 和 232 次 RAV)中进行了 AVS。IVC 的中位肾上腺素水平为 19(14 和 34),LAV 为 3811(1870 和 6915),RAV 为 2897(1500 和 5288)。IVC 的中位去甲肾上腺素水平为 325(186 和 479),LAV 为 1450(896 和 2050),RAV 为 786(436 和 1582)。LAV 和 RAV 肾上腺素水平(P=0.024)以及 LAV 和 RAV 去甲肾上腺素水平(P=0.002)存在差异。
本项广泛的 AVS 经验表明,无嗜铬细胞瘤患者的 AV 儿茶酚胺水平存在广泛的“正常”范围,这表明 AVS 确定嗜铬细胞瘤和双侧肾上腺结节患者疾病侧别的效用可能有限。